Characterization of the activity of RBCs bound by hTM-scFv fusions and their therapeutic efficacy in a microfluidic model of inflammatory thrombosis. Characterization.

Slides:

Advertisements

Similar presentations

Red blood cells mediate the onset of thrombosis in the ferric chloride murine model by Justin D. Barr, Anil K. Chauhan, Gilbert V. Schaeffer, Jessica K.

Advertisements

Acalabrutinib and ibrutinib therapy cause dysfunctional GPVI-mediated platelet aggregation. Acalabrutinib and ibrutinib therapy cause dysfunctional GPVI-mediated.

Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34+ cells are.

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice by Sravya Kattula, James R. Byrnes,

by Miguel Vicente-Manzanares, Aranzazu Cruz-Adalia, Noa B

Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,

Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory.

A revised model for the secretion of tPA and cytokines from cultured endothelial cells by Laura Knipe, Athinoula Meli, Lindsay Hewlett, Ruben Bierings,

Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease by Diana R. Gutsaeva, James B. Parkerson,

by Roel Polak, Bob de Rooij, Rob Pieters, and Monique L. den Boer

Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signaling by Alexey M. Belkin, Galina.

Platelet depletion by anti-CD41 (αIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering.

Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3 by Cindy L. Yap, Karen.

by Maria-Isabel Fernandez, Mélina L

A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages by Wei Xia, Andrew R. Hilgenbrink,

by Lisa A. Porter, I. Howard Cukier, and Jonathan M. Lee

Athena Kalyvas, Samuel David Neuron

Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito by Shigeto Yoshida,

Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody.

by Laurent O. Mosnier, Andrew J

Alterations in platelet secretion differentially affect thrombosis and hemostasis by Smita Joshi, Meenakshi Banerjee, Jinchao Zhang, Akhil Kesaraju, Irina.

Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-α: a basis for local.

Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1)‏ by Kaisa Koskinen, Petri.

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies by.

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,

Hemolysis is a primary ATP-release mechanism in human erythrocytes

Differential Effect of E-Selectin Antibodies on Neutrophil Rolling and Recruitment to Inflammatory Sites by Carroll L. Ramos, Eric J. Kunkel, Michael B.

by Anupama Narla, Shilpee Dutt, J

Coordination of platelet agonist signaling during the hemostatic response in vivo by Jian Shen, Sara Sampietro, Jie Wu, Juan Tang, Shuchi Gupta, Chelsea.

Apoptotic Vascular Endothelial Cells Become Procoagulant

Volume 20, Issue 2, Pages (February 2012)

by Jamie Honeychurch, Alison L. Tutt, Thomas Valerius, Ingmar A. F. M

C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald.

Α-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 by Lucinda Furci, Francesca Sironi, Monica Tolazzi,

by Michael Bezuhly, Robyn Cullen, Charles T. Esmon, Steven F

The Cytoskeleton Regulates Cell Attachment Strength

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis by Manasa K. Nayak, Nirav Dhanesha,

Linda Balabanian, Christopher L. Berger, Adam G. Hendricks

Enhancing functional platelet release in vivo from in vitro–grown megakaryocytes using small molecule inhibitors by Danuta Jarocha, Karen K. Vo, Randolph.

Sialylated Ab-ICs promote enhanced humoral immune responses.

Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production by Soe Soe Htwe, Hidenori Wake, Keyue.

Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice by Rikke Stagaard, Carsten Dan Ley, Kasper Almholt,

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.

Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation by Frederic Lagarrigue, Alexandre R. Gingras,

AG-221 can reduce intracellular 2HG levels and induce differentiation in primary human IDH2R140Q- or IDH2R172K-mutant AML patient samples treated ex vivo.

by Cheryl L. Maier, Amanda Mener, Seema R. Patel, Ryan P

ICAM-1–targeted thrombomodulin mitigates tissue factor–driven inflammatory thrombosis in a human endothelialized microfluidic model by Colin F. Greineder,

by Carlos H. Villa, Daniel C. Pan, Ian H. Johnston, Colin F

Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins by Amy K. L. Chui, Tilini N. Gunatillake,

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib by Alexander P. Bye, Amanda J. Unsworth,

Janina Jamasbi et al. BTS 2016;1:

T exosomes bind MAdCAM-1 via RA-increased integrin α4β7.

2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia by Elizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski,

Volume 20, Issue 2, Pages (February 2012)

The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency by Pradeep Bangalore-Prakash, Laura.

Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL by Kallesh D. Jayappa, Craig A.

Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models by Trisha R. Sippel, Stefan Radtke, Tayla.

Neutrophils contain bacteria inside the phagolysosome for more than 2 days. Neutrophils contain bacteria inside the phagolysosome for more than 2 days.

by Kelly E. Johnson, Julia R. Ceglowski, Harvey G. Roweth, Jodi A

Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies by Nadine Müller-Calleja, Svenja.

Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor by Gauthami Jalagadugula, Lawrence.

Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura by Liang Zheng, Yingying.

Ventral mouse V-SVZ cells exhibit higher mTORC1 activity than dorsal cells and are responsive to rapamycin. Ventral mouse V-SVZ cells exhibit higher mTORC1.

Trends in the use of head CT and advanced imaging in patients treated with IV thrombolysis from 2008 to Trends in the use of head CT and advanced.

Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state by Jeremy P. Wood, Lisa M.

Fig. 3 Prophylactic or therapeutic use of DECON protects from herpes infections in vitro. Prophylactic or therapeutic use of DECON protects from herpes.

Fig. 1 Prophylactic, neutralization, and therapeutic efficacy of HPAC.

Myeloproliferative neoplasms and thrombosis

Arati Sridharan, Chetan Patel, Jit Muthuswamy

Presentation transcript:

Characterization of the activity of RBCs bound by hTM-scFv fusions and their therapeutic efficacy in a microfluidic model of inflammatory thrombosis. Characterization of the activity of RBCs bound by hTM-scFv fusions and their therapeutic efficacy in a microfluidic model of inflammatory thrombosis. (A) APC generation by RBCs loaded with hTM-scFv demonstrates a dose- and copy-number–dependent response in APC generation as measured by chromogenic assay. hTM-aBand3 (blue circles) showed about twofold higher APC generation per RBC compared with hTM-aRhCE (red triangles), although copy numbers are expected to be fivefold to 10-fold higher. Soluble hTM (shTM)-treated RBCs are shown as a nonbinding control (green open squares). (B) Comparison of APC-generative capacity of sTM vs hTM-scFv fusions (added at 50 nM) in a high Hct (20%) RBC suspension. Mean ± SD is shown; n = 3 for each condition (*P < .05 vs sTM, 1-way ANOVA with Holm-Sidak correction for multiple comparisons). A slight reduction in activity was seen for hTM-aBand3 but not hTM-aRhCE. (C) Fibrin generation on TNF-α–activated, endothelialized microfluidic channels perfused with human whole blood preincubated with either PBS control (green open squares), shTM control (orange crosses), hTM-Wrb (blue circles), or hTM-aRh17 (red triangles). Both fusion proteins (and shTM+ control) significantly reduced fibrin generation (*P < .05 vs untreated, 1-way ANOVA with Holm-Sidak correction for multiple comparisons) as compared with the control channel. An increase in fibrin generation was noted toward the end of the observation period for the hTM-aWrb–treated channels. (D) hTM-aRh17 treatment (red triangles) more effectively reduced platelet and leukocyte adhesion (quantified with calcein AM fluorescence) than hTM-aWrb (blue circles) vs untreated control (open squares). hTM-Rh17 treatment was similar to shTM+ control (crosses). For panels C-D, mean ± standard error of the mean (SEM) for 2 independent channels is shown. (E) Representative composite images of whole blood (fibrin in red [anti-fibrin-AlexaFluor568 stain], platelets and leukocytes in green [calcein AM stain], brightfield image in gray) flowing through endothelialized channels at the end of the observation period (t = 20 minutes). Fibrin is decreased in both fusion-treated channels. An increase in platelet adhesion with associated fibrin (yellow, arrowhead) is seen in the hTM-aWrb–treated channels compared with hTM-aRh17 (see supplemental Videos 1-4 for the full time course). Carlos H. Villa et al. Blood Adv 2018;2:165-176 © 2018 by The American Society of Hematology